Will Abbott Laboratories Remain A Top Dividend Aristocrat Stock Going Forward?


  • ABT has been growing its dividends for OVER half a century and is one of only 37 US stocks to do so.
  • We examine if ABT has ample elbow room to service the dividend.
  • We conclude with some thoughts on the technicals and the valuations.
Collage image of hand dropping coins into another hand

We Are


Most investors latch on to Abbott Laboratories (NYSE:ABT) for its growing prowess in the broad healthcare space, but it also helps that this stock has a resplendent dividend theme, which only makes the investment case even more alluring. The image below

Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Leave a Reply

Your email address will not be published. Required fields are marked *